Randomized Dose-Ranging Study of the 14-Day Early Bactericidal Activity of Bedaquiline (TMC207) in Patients with Sputum Microscopy Smear-Positive Pulmonary Tuberculosis

Bedaquiline is a new antituberculosis agent targeting ATP synthase. This randomized, double-blinded study enrolling 68 sputum smear-positive pulmonary tuberculosis patients evaluated the 14-day early bactericidal activity of daily doses of 100 mg, 200 mg, 300 mg, and 400 mg bedaquiline, preceded by...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Diacon, Andreas H., Dawson, Rodney, Von Groote-Bidlingmaier, Florian, Symons, Gregory, Venter, Amour, Donald, Peter R., Conradie, Almari, Erondu, Ngozi, Ginsberg, Ann M., Egizi, Erica, Winter, Helen, Becker, Piet, Mendel, Carl M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2013
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3632959/
https://ncbi.nlm.nih.gov/pubmed/23459487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02243-12
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados